In an article published in the Pharmaceutical Executive in March, Lise Kingo, executive vice president of Corporate Stakeholder Relations, Novo Nordisk A/S, is interviewed about sustainability.

The article, “Sustainability drives Pharma’s future” points out the growing conviction that the balancing of economic, social and environmental issues is an indication of a company’s future success. And that investors look at these issues when evaluating companies’ “financial fitness.”

Following this lead-in, the story calls attention to Novo Nordisk’s
number-one ranking in the Dow Jones list of most-sustainable companies.

Read a pdf version of the full article.

To news archive.